Actively Recruiting
Observational Study to Evaluate Effectiveness of Subcutaneous Foslevodopa/Foscarbidopa for Advanced Parkinson's Disease Patients in Belgium
Led by AbbVie · Updated on 2026-04-07
120
Participants Needed
10
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Parkinson's disease (PD) is a neurological condition that affects the brain and worsens over time, with symptoms such as tremors, stiffness, and slowness of movement. The progression rate varies among individuals. This research aims to evaluate how effective Foslevodopa/Foscarbidopa is for adults with advanced Parkinson's Disease in routine clinical practice in Belgium. The study is observational and led by AbbVie. Participants will receive Foslevodopa/Foscarbidopa through subcutaneous infusion as prescribed by their physicians, following local guidelines. Around 120 adults will be enrolled across 15 sites in Belgium. Treatment and dosing will be managed as part of routine care without additional intervention from the study team. Participants will be followed for up to 18 months with regular visits to the hospital or clinic as part of their usual care. Researchers will assess changes in "OFF Time," meaning periods when symptoms are not well controlled, using a standardized Parkinson's rating scale over approximately 6 months. There is no expected extra burden for participants beyond their normal treatment visits.
CONDITIONS
Brief Title
A Study to Assess Change in Disease Symptoms in Adult Participants With Advanced Parkinson Disease Using Subcutaneous Foslevodopa/Foscarbidopa in Belgium
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Participant diagnosed with Advanced Parkinson's Disease (PD), aged 18 years or older able to provide voluntary informed consent.
- Participant evaluated for commercially available continuous subcutaneous Foslevodopa/Foscarbidopa in the hospital at the clinician's discretion as part of routine clinical care.
- Intention to administer subcutaneous Foslevodopa/Foscarbidopa made prior to and independent of recruitment into the study.
You will not qualify if you...
- Participant currently participating in an interventional research study (not including noninterventional studies) during Foslevodopa/Foscarbidopa administration.
- Participant evaluated for continuous subcutaneous Foslevodopa/Foscarbidopa outside of the hospital.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to approximately 6 months
Participants who undergo routine care with subcutaneous Foslevodopa/Foscarbidopa are observed to evaluate changes in disease symptoms over time.
Visits as part of routine clinical care
Trial Site Locations
Total: 10 locations
1
Universitair Ziekenhuis Antwerpen /ID# 279434
Edegem, Antwerpen, Belgium, 2650
Actively Recruiting
2
Chu Tivoli /ID# 279455
La Louvière, Hainaut, Belgium, 7100
Actively Recruiting
3
Centre Hospitalier De Wallonie Picarde - Site Notre Dame /ID# 279452
Tournai, Hainaut, Belgium, 7500
Actively Recruiting
4
Jessa Ziekenhuis - Campus Virga Jesse /ID# 279454
Hasselt, Limburg, Belgium, 3500
Actively Recruiting
5
UZ Gent /ID# 279433
Ghent, Oost-Vlaanderen, Belgium, 9000
Actively Recruiting
6
Universitair Ziekenhuis Leuven /ID# 279439
Leuven, Vlaams-Brabant, Belgium, 3000
Actively Recruiting
7
AZ Sint-Jan Brugge /ID# 279422
Bruges, West-Vlaanderen, Belgium, 8000
Actively Recruiting
8
Az Groeninge Campus Kennedylaan /ID# 279423
Kortrijk, West-Vlaanderen, Belgium, 8500
Actively Recruiting
9
AZ Oostende /ID# 279461
Ostend, West-Vlaanderen, Belgium, 8400
Actively Recruiting
10
AZ-Delta. /ID# 279437
Roeselare, West-Vlaanderen, Belgium, 8800
Actively Recruiting
Research Team
C
Clementine Semanaz
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here